Pharma channel feed

Left be­hind at the Covid vac­cine start­ing line, Cure­Vac files suit against BioN­Tech over megablock­buster IP claims

3 years ago
Law

Seagen touts full PhII Tukysa da­ta as it plots col­orec­tal can­cer ex­pan­sion

3 years ago
R&D

From Tam­pa to Mu­nich, Am­gen’s ‘Places’ cam­paign in­tro­duces its lo­ca­tions around the world

3 years ago
Marketing

Bio­haven takes mi­graine cam­paign to pa­tients' Twit­ter feeds, months ahead of Pfiz­er takeover

3 years ago
Marketing

US gov­ern­ment more than dou­bles the sup­ply of mon­key­pox vac­cine

3 years ago
Manufacturing

What’s been on in­flu­en­tial on­col­o­gist­s' minds? Most­ly AS­CO, but al­so health eq­ui­ty, ac­cord­ing to new Har­ris Poll re­search

3 years ago
Marketing

No­var­tis to de­cide on spin­ning off $25B gener­ics arm San­doz by year's end

3 years ago

Bay­er's re­search and de­vel­op­ment teams set­tle in­to new, $140M Kendall Square digs

3 years ago
R&D

Phar­ma in­dus­try spent a record $389M on US lob­by­ing in 2021, but more is like­ly com­ing this year — re­port

3 years ago

GSK se­lects ‘thought­ful’ mul­ti­ple myelo­ma pro­gram for in­au­gur­al ‘Think Tank’ chal­lenge win

3 years ago
Marketing

New re­search ar­gues drug pric­ing ne­go­ti­a­tions would stymie in­no­va­tion, as De­moc­rats fight for re­vised pro­pos­al

3 years ago
FDA+

No­var­tis to re­sume the pro­duc­tion of two ra­di­oli­gand ther­a­pies af­ter re­solv­ing qual­i­ty is­sues

3 years ago
Manufacturing

An­oth­er biotech grabs the axe, chop­ping R&D in a ma­jor re­or­ga­ni­za­tion as drug sales dis­ap­point

3 years ago
People
R&D

No­var­tis, BeiGene lay out front­line PhI­II da­ta for PD-1 drug as sec­ond-line PDU­FA date looms

3 years ago
R&D
China

Roche, Pfiz­er top list of ESG lead­ers in pa­tient group­s' view, but many still think phar­mas can do bet­ter

3 years ago
Marketing

Gilead scores a $33M set­tle­ment from its cam­paign against ‘colos­sal fi­nan­cial fraud’

3 years ago
Law

HHS to dis­trib­ute 1.6M mon­key­pox vac­cine dos­es this year

3 years ago

Vedan­ta opens man­u­fac­tur­ing fa­cil­i­ty to pro­duce lead can­di­date as it heads for PhI­II

3 years ago
Manufacturing

Eu­ro­pean Com­mis­sion says it does­n't have texts be­tween pres­i­dent Ur­su­la von der Leyen and Pfiz­er CEO Al­bert Bourla

3 years ago
Coronavirus

Feel­ing the heat of the bear mar­ket, eye dis­ease biotech to im­ple­ment 'ex­pense stream­lin­ing' plan and lay off 50

3 years ago
People

Sanofi to cut in­sulin prices for unin­sured from $99 to $35, match­ing the in­sulin cap com­ing through Con­gress

3 years ago

Up­dat­ed: Some phar­ma com­pa­nies promise to cov­er abor­tion-re­lat­ed trav­el costs — while oth­ers won't go that far yet

3 years ago

Au­robindo Phar­ma re­ceives warn­ing let­ter from In­di­a's SEC fol­low­ing more FDA ques­tion marks

3 years ago
FDA+
Manufacturing

Eu­rope to buy 110k dos­es of Bavar­i­an Nordic's mon­key­pox vac­cine — as EU-li­censed vac­cine not eas­i­ly ac­ces­si­ble

3 years ago
First page Previous page 190191192193194195196 Next page Last page
A service from the Financial Times